WORLDREMIT
4.2.2021 02:56:08 CET | Business Wire | Press release
WorldRemit, a leading digital cross-border payments business has announced the winners of its recent Grainsmart store franchise promotion to help customers give their beneficiaries the opportunity to start a business in the Philippines. Customers qualified for the promotion by sending money to the Philippines and nominating a beneficiary of their choice. The winners include frontline healthcare workers and teachers from a number of countries including the United Kingdom, Norway, Australia, Canada, New Zealand, Sweden and the United States. Beneficiaries will now be opening Grainsmart stores across the Philippines in places which include Cebu, Davao, San Carlos and Tagum City.
“We’re so pleased to give recipients this great opportunity to start a business that will help them to support their families and become more financially stable. The franchisees have the option to expand these businesses and potentially create job opportunities for members of the wider community. This underlines our commitment to helping Overseas Filipino Workers to support those dearest to them back home,” said Earl Melivo, Country Director for the Philippines at WorldRemit.
Benjamin Batac, CEO at Grainsmart added, “It’s an honour to partner with a company like WorldRemit that shares our values. With many of the franchise contracts already signed, this promotion will create sustainable jobs and also give much-needed support to Filipino farmers, many of whom are facing challenges due to the pandemic and recent natural disasters”.
Winner Emilie Ann Estavas who works as a healthcare assistant in a care home in Oxfordshire said, “I’m very happy and excited with the prize and so grateful to WorldRemit and Grainsmart. It is really a surprise. The Pangkabuhayan package will help my family back in the Philippines to start a business which is a huge blessing and a big help. It is a great opportunity and I’m planning to expand the business while we are here still working abroad. I am hoping and praying that God will bless the business and make it prosper so that in the near future it will help us to retire early, go home and continue running the business with my family. Fingers crossed!”.
Winner and frontline worker Melissa Zibas has chosen her cousin Adan who lives in San Carlos City, Pangasinan as her beneficiary. She said, “Adan is a former seafarer and is pretty adventurous like me so I know he’ll make a huge success of the Grainsmart business. We’re a very close family so I hope we can grow the business and include other members of our family. The covid-19 pandemic has really tested everyone's lives so it's great to start a business that will be needed by people as rice is our staple food”.
Rosa Mae who lives in Norway and is studying to become a youth worker, chose her sister Rhea as her beneficiary. Rhea who lives and works in Tagum City as a doctor’s secretary said, “I’m so grateful to my big sister for giving me this opportunity. I miss her so much now that she lives over 10,000 miles away in Oslo. Sending transfers through WorldRemit is her way of supporting and staying connected to us and now it has given me the chance to start my own business. We grew up in Davao de Oro and our parents still live there so I’m looking forward to running the Grainsmart franchise with them”.
Each Grainsmart franchise business package includes:
- 60 sacks (25 kg each) of rice
- A tablet that’s fully set up for a bills payment center account
- Business signage, marketing collateral, and other business paraphernalia
- An online training and mentorship program – to provide guidance for setting up the business for success
As well as the COVID-19 pandemic, Filipinos have also had to deal with the devastation caused by Super Typhoon Goni and Typhoon Vamco, which have displaced thousands and destroyed livelihoods.
Take advantage of competitive exchange rates for the Philippine peso by visiting www.worldremit.com or downloading the app.
Winners were announced on the WorldRemit Facebook page (https://www.facebook.com/WorldRemit/ ).
For more details visit www.worldremit.com/pangkabuhayan .
WorldRemit
WorldRemit is a leading digital cross-border payments business. We disrupted an industry previously dominated by offline legacy players by taking international money transfers online - making them safer, faster and lower-cost. We currently send from more than 50 countries to 130+ receive countries, operate in 6,500 money transfer corridors worldwide and employ over 1,100 people worldwide.
On the sending side WorldRemit is 100% digital (cashless), increasing convenience and enhancing security. For those receiving money, the company offers a wide range of options including bank deposit, cash collection, mobile airtime top-up and mobile money.
Backed by Accel, TCV and Leapfrog – WorldRemit’s headquarters are in London, United Kingdom with regional offices in the United States, Canada, Australia, New Zealand, Hong Kong, Singapore, Malaysia, the Philippines, South Africa, Somaliland, Uganda, Kenya, Rwanda, Tanzania, Zimbabwe and Belgium.
For more information visit www.worldremit.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20210203006021/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 14:00:00 CEST | Press release
Fuel manufactured at Springfields has generated enough energy to supply the UK’s electricity demand for 26 years, avoiding the emission of nearly 3 billion tonnes of CO2 The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 5
HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 14:00:00 CEST | Press release
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
Samsung Biologics Strike: Labor Union Warns of CDMO Supply Chain Risks Following Overwhelming Vote30.3.2026 11:52:00 CEST | Press release
Union members overwhelmingly approve strike action with 95.52% voting in favor on a 95.38% turnout, clearing the final legal hurdle after mediation ceased.Union emphasizes this is a fight against structural corporate governance issues, citing unresolved allegations concerning unfair labor practices and ESG compliance risks.Management adhered to a group-level wage guideline rather than bargaining on the basis of Samsung Biologics' own performance, exposing a lack of independent bargaining authority. The Samsung Biologics Labor Union (President: Jaesung Park), representing approximately 75% of the company's total employees, announced today that its members have overwhelmingly voted in favor of a strike, with 95.52% voting in favor on a 95.38% turnout during a voting period from March 24 to March 29. Following the Incheon Regional Labor Relations Commission's decision to cease mediation, the union has now secured the legal mandate to strike. The union stressed that this strike is not mere
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
